Evidence map›Paper›PMID 19701097›Full record

ReviewJournal of cardiovascular pharmacology2009

Mechanisms of gap junction traffic in health and disease.

Geoffrey G Hesketh, Jennifer E Van Eyk, Gordon F Tomaselli

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cardiovascular pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. RSC advances · 2025
    Article
  5. Review
  6. Review
  7. Glycation in the cardiomyocyte.Vitamins and hormones · 2024
    Review
  8. Article
  9. Endothelial cell dysfunction in cardiac disease: driver or consequence?Frontiers in cell and developmental biology · 2023
    Review
  10. Contemporary management of ventricular arrhythmias in heart failure.American journal of cardiovascular disease · 2023
    Review
  11. Article
  12. Intracellular trafficking pathways of Cx43 gap junction channels.Biochimica et biophysica acta. Biomembranes · 2018
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Geoffrey G HeskethDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Jennifer E Van Eyk
Gordon F Tomaselli
Johns Hopkins University · US

Funding

Pathobiology of Cardiac Dyssynchrony &ResynchronizationP01HL077180 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI VAN EYK, JENNIFER E · 2004 to 2014
$22.8M
The Systems Biology of Sudden Cardiac DeathR33HL087345 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI WINSLOW, RAIMOND LESTER · 2007 to 2009
$854k
NHLBI NIH HHS P01 HL077180NHLBI NIH HHS R33 HL 087345NHLBI NIH HHS R33 HL087345
6 · The paper itself

Abstract

Gap junctions (GJs) allow direct communication between cells. In the heart, GJs mediate the electrical coupling of cardiomyocytes and as such dictate the speed and direction of cardiac conduction. A prominent feature of acquired structural heart disease is remodeling of GJ protein expression and localization concomitant with increased susceptibility to lethal arrhythmias, leading many to hypothesize that the two are causally linked. Detailed understanding of the cellular mechanisms that regulate GJ localization and function within cardiomyocytes may therefore uncover potential therapeutic strategies for a significant clinical problem. This review will outline our current understanding of GJ cell biology with the intent of highlighting cellular mechanisms responsible for GJ remodeling associated with cardiac disease.

Indexed as

AnimalsCell CommunicationConnexinsGap JunctionsHeart Conduction SystemHeart DiseasesHumansMyocytes, CardiacPhosphorylationProtein Interaction Domains and MotifsConnexins

Identifiers

PMID19701097
PMCPMC2909441
OpenAlexW2075948235

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.